Baseline | After-intervention | P value | |
---|---|---|---|
N | 29 | 29 | |
Patient characteristics | |||
Age (years), median (IQR) | 36.0 (29.5 – 42.5) | ||
Gender (male), n (%) | 17 (59%) | ||
Clinical characteristics | |||
Peak eosinophil count, median (IQR) | 50.0 (40.0 – 80.0) | 25.0 (4.5 – 40.0) | < 0.0001a,* |
Histological remission, yes, n (%) | 10 (35) | ||
SDI, median (IQR) | 5.0 (4.0 – 6.0) | 2.0 (0.0 – 4.0) | < 0.0001a,* |
EREFS score (total), median (IQR) | 5.0 (4.0 – 5.0) | 3.0 (1.0 – 4.0) | < 0.0001a,* |
Fibrotic score, median (IQR) | 2.0 (1.0 – 3.0) | 1.0 (1.0 – 2.0) | 0.0622a |
Inflammatory score, median (IQR) | 3.0 (2.0 – 3.0) | 2.0 (1.0 – 2.0) | < 0.001a,* |
Food impactionI (yes), n (%) | 16 (55) | 9 (31) | NS |